QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Castle Biosciences (CSTL) SEC Filings & 10K Form

$18.06
-6.33 (-25.95%)
(As of 02/29/2024 ET)

Recent Castle Biosciences SEC Filings

DateFilerForm TypeView
02/28/2024
4:08 PM
Castle Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
4:15 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/09/2024
3:49 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:43 AM
Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/07/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:04 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:16 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:06 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:32 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:39 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
5:24 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
6:39 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:28 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:33 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
3:38 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:46 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:49 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
3:50 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/01/2023
3:43 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:30 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:34 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:37 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144/A
11/22/2023
3:22 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:20 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
4:25 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:14 PM
Castle Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/06/2023
3:40 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:23 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:26 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:51 PM
Castle Biosciences (Issuer)
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:41 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:06 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:10 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:48 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:35 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:38 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:40 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:42 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:44 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:46 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:33 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:02 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
3:16 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
4:55 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:57 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:38 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:42 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:45 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:48 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:52 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
12:43 PM
Castle Biosciences (Filer)
Form DEFA14A
05/08/2023
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
3:26 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2023
3:22 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2023
3:44 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2023
3:40 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2023
3:37 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2023
3:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2023
4:25 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2023
4:17 PM
Castle Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CSTL) was last updated on 2/29/2024 by MarketBeat.com Staff